BRENTUXIMAB VEDOTIN for Lymphoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 168 adverse event reports in the FDA FAERS database where BRENTUXIMAB VEDOTIN was used for Lymphoma.
Most Reported Side Effects for BRENTUXIMAB VEDOTIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 1,370 | 14.1% | 318 | 492 |
| Neuropathy peripheral | 695 | 7.2% | 82 | 174 |
| Pyrexia | 693 | 7.1% | 140 | 476 |
| Febrile neutropenia | 684 | 7.0% | 80 | 477 |
| Death | 602 | 6.2% | 601 | 125 |
| Neutropenia | 561 | 5.8% | 99 | 267 |
| Hodgkin's disease | 512 | 5.3% | 157 | 111 |
| Nausea | 392 | 4.0% | 74 | 235 |
| Diarrhoea | 385 | 4.0% | 85 | 231 |
| Anaemia | 374 | 3.9% | 89 | 223 |
| Thrombocytopenia | 358 | 3.7% | 76 | 185 |
| Weight decreased | 352 | 3.6% | 91 | 190 |
| Disease progression | 313 | 3.2% | 98 | 44 |
| Drug ineffective | 308 | 3.2% | 68 | 63 |
| Pneumonia | 302 | 3.1% | 112 | 201 |
Other Indications for BRENTUXIMAB VEDOTIN
Hodgkin's disease (4,665)
Product used for unknown indication (1,003)
Anaplastic large cell lymphoma t- and null-cell types (406)
Peripheral t-cell lymphoma unspecified (366)
Anaplastic large-cell lymphoma (358)
Cutaneous t-cell lymphoma (314)
Hodgkin's disease refractory (279)
Diffuse large b-cell lymphoma (248)
T-cell lymphoma (199)
Hodgkin's disease recurrent (157)
Other Drugs Used for Lymphoma
RITUXIMAB (3,142)
CYCLOPHOSPHAMIDE (1,729)
VINCRISTINE (1,452)
LENALIDOMIDE (1,427)
DOXORUBICIN (1,420)
ETOPOSIDE (915)
IBRUTINIB (896)
PREDNISONE (672)
METHOTREXATE (647)
CYTARABINE (645)